Trilex Pharmaceuticals Inc.
This article was originally published in Start Up
Executive Summary
Pharmaceuticals; Anti-idiotype vaccines for cancer. Trilex is develping murine monoclonal antibodies known as anti-idiotype antibodies for a range of different cancers. The vaccines are intended to be given at intervals of weeks to months to help keep up the immune response, as a primary therapy, or as adjuvants to chemotherapy or radiation.